NasdaqCM:IMNMBiotechs
Assessing Immunome (IMNM) Valuation As Premium P/B And DCF Signals Point In Different Directions
Initial context for Immunome stock
Immunome (IMNM) has attracted fresh attention after recent share price swings, with the stock now around US$22.19 and a market value near US$2.64b. This has prompted investors to reassess how current fundamentals line up with expectations.
See our latest analysis for Immunome.
Recent trading has been choppy, with a 1 day share price return of a 4.64% decline and a 7 day share price return of a 3.27% decline. However, the 1 year total shareholder return of...